Nitric oxide-sensitive soluble guanylyl cyclase activity is preserved in internal mammary artery of type 2 diabetic patients.
Witte
Klaus
K
Faculty of Clinical Medicine Mannheim, Institute of Pharmacology and Toxicology, University of Heidelberg, Mannheim, Germany.
Hachenberger
Jochen
J
Castell
Maria F
MF
Vahl
Christian F
CF
Haller
Christlieb
C
D000368:Aged; D003327:Coronary Disease / Q000201:enzymology / Q000453:epidemiology; D006152:Cyclic GMP / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000201:enzymology*; D003925:Diabetic Angiopathies / Q000201:enzymology / Q000453:epidemiology*; D005260:Female; D006162:Guanylate Cyclase / Q000378:metabolism*; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology; D008297:Male; D008323:Mammary Arteries / Q000201:enzymology*; D008875:Middle Aged; D009569:Nitric Oxide / Q000494:pharmacology*; D020030:Nitric Oxide Donors / Q000494:pharmacology; D009589:Nitrogen Oxides; D018487:Ventricular Dysfunction, Left / Q000201:enzymology / Q000453:epidemiology
D006834:Hydrazines; D020030:Nitric Oxide Donors; D009589:Nitrogen Oxides; D009569:Nitric Oxide; C084012:1,1-diethyl-2-hydroxy-2-nitrosohydrazine; D006162:Guanylate Cyclase; D006152:Cyclic GMP